{"id":"W4402558698","doi":"10.1016/j.annonc.2024.08.2142","title":"1139TiP IDE196 (darovasertib) in combination with crizotinib versus investigator’s choice of treatment as first-line therapy in HLA-A2 negative metastatic uveal melanoma","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Crizotinib; Melanoma; Oncology; Second-line therapy; Internal medicine; Metastatic melanoma; Second line; Dermatology; First line; Cancer research; Chemotherapy; Lung cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007563871,0.0003436119,0.001632616,0.0003165045,0.0002472317,0.0007751239,0.0004330387,0.0005639462,0.004654297],"category_scores_gemma":[0.001214904,0.0001899332,0.0009079389,0.0003099068,0.0002536758,0.0005099501,0.0002404949,0.001820944,0.0005468128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008877923,"about_ca_system_score_gemma":0.0008720974,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001682029,"about_ca_topic_score_gemma":0.007156176,"domain_scores_codex":[0.9996467,0.000140157,0.00002564911,0.00006025056,0.00003886475,0.00008846854],"domain_scores_gemma":[0.9995694,0.0001420696,0.00006213922,0.00001969909,0.00001931246,0.0001874843],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4946331,0.006483698,0.01162802,0.000990702,0.002302491,0.0006348609,0.0001725015,0.005670325,0.01792045,0.001016369,0.01187562,0.4466719],"study_design_scores_gemma":[0.3421895,0.4106842,0.1183392,0.0009909525,0.009682296,0.005299098,0.0006859596,0.03564544,0.01794112,0.003688604,0.0545262,0.0003274211],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9754165,0.01302384,0.0003440941,0.001274391,0.0005560647,0.0001769147,0.0006421625,0.00008784907,0.00847825],"genre_scores_gemma":[0.994042,0.002667459,0.0005841695,0.0004205565,0.0001808563,0.00008480916,0.0004514245,0.00001798374,0.001550804],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004654297,"threshold_uncertainty_score":0.01557016,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1300729819041251,"score_gpt":0.4199939671503539,"score_spread":0.2899209852462288,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}